Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics

Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) -- PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing a first-in-class therapeutic platform designed to restore cellular secretion mechanisms.

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be

MDB Capital Holdings Announces Transitions In Its Board of Directors

MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service

PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy

New PatentVest Pulse analysis examines Elon Musk's SpaceX, Jeff Bezos–backed Blue Origin, Rocket Lab, and China's growing influence New PatentVest Pulse analysis examines Elon Musk's SpaceX, Jeff Bezos–backed Blue Origin, Rocket Lab, and China's growing influence